178 related articles for article (PubMed ID: 34600647)
41. Reaction kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range.
Wang R; Zhou W; Jiang X
J Agric Food Chem; 2008 Apr; 56(8):2694-701. PubMed ID: 18361498
[TBL] [Abstract][Full Text] [Related]
42. Niosomal Nanocarriers for Enhanced Dermal Delivery of Epigallocatechin Gallate for Protection against Oxidative Stress of the Skin.
Li D; Martini N; Wu Z; Chen S; Falconer JR; Locke M; Zhang Z; Wen J
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456560
[TBL] [Abstract][Full Text] [Related]
43. Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability.
Ge J; Tan BX; Chen Y; Yang L; Peng XC; Li HZ; Lin HJ; Zhao Y; Wei M; Cheng K; Li LH; Dong H; Gao F; He JP; Wu Y; Qiu M; Zhao YL; Su JM; Hou JM; Liu JY
J Mol Med (Berl); 2011 Jun; 89(6):595-602. PubMed ID: 21331509
[TBL] [Abstract][Full Text] [Related]
44. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention.
Proniuk S; Liederer BM; Blanchard J
J Pharm Sci; 2002 Jan; 91(1):111-6. PubMed ID: 11782902
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
Ramesh N; Mandal AKA
Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
[TBL] [Abstract][Full Text] [Related]
46. Preparation of Type-A Gelatin/Poly-γ-Glutamic Acid Nanoparticles for Enhancing the Stability and Bioavailability of (-)-Epigallocatechin Gallate.
Zhang W; Shen H; Li Y; Yang K; Lei P; Gu Y; Sun L; Xu H; Wang R
Foods; 2023 Apr; 12(9):. PubMed ID: 37174287
[TBL] [Abstract][Full Text] [Related]
47. Liposomal Formulations for an Efficient Encapsulation of Epigallocatechin-3-gallate: An in- Silico/Experimental Approach.
Laudadio E; Minnelli C; Amici A; Massaccesi L; Mobbili G; Galeazzi R
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462955
[TBL] [Abstract][Full Text] [Related]
48. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
[TBL] [Abstract][Full Text] [Related]
49. Co-encapsulation of Epigallocatechin Gallate (EGCG) and Curcumin by Two Proteins-Based Nanoparticles: Role of EGCG.
Yan X; Zhang X; McClements DJ; Zou L; Liu X; Liu F
J Agric Food Chem; 2019 Dec; 67(48):13228-13236. PubMed ID: 31610115
[TBL] [Abstract][Full Text] [Related]
50. On the role of epigallocatechin-3-gallate in protecting phospholipid molecules against UV irradiation.
Pires F; Geraldo VPN; Antunes A; Marletta A; Oliveira ON; Raposo M
Colloids Surf B Biointerfaces; 2019 Jan; 173():312-319. PubMed ID: 30308456
[TBL] [Abstract][Full Text] [Related]
51. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.
Lambert JD; Kwon SJ; Ju J; Bose M; Lee MJ; Hong J; Hao X; Yang CS
Carcinogenesis; 2008 Oct; 29(10):2019-24. PubMed ID: 18684728
[TBL] [Abstract][Full Text] [Related]
52. Zeolites with Divalent Ions as Carriers in the Delivery of Epigallocatechin Gallate.
Sandomierski M; Chojnacka M; Ratajczak M; Voelkel A
ACS Biomater Sci Eng; 2023 Sep; 9(9):5322-5331. PubMed ID: 37540564
[TBL] [Abstract][Full Text] [Related]
53. Enhanced Oral Bioavailability of Progesterone in Bilosome Formulation: Fabrication, Statistical Optimization, and Pharmacokinetic Study.
Maheshwari R; Bhatt LK; Wairkar S
AAPS PharmSciTech; 2024 Feb; 25(2):29. PubMed ID: 38302633
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization.
Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA
J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568
[TBL] [Abstract][Full Text] [Related]
55. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
Matsuzaki S; Darcha C
Hum Reprod; 2014 Aug; 29(8):1677-87. PubMed ID: 24876174
[TBL] [Abstract][Full Text] [Related]
56. Insight into the structural characteristics of self-assembled liposome with epigallocatechin gallate/alcohol dehydrogenase.
Zhang X; Liu L; Jiao X; Su K; Cheng W; Xu B
Colloids Surf B Biointerfaces; 2024 Jun; 238():113917. PubMed ID: 38615391
[TBL] [Abstract][Full Text] [Related]
57. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and
El-Nabarawi MA; Shamma RN; Farouk F; Nasralla SM
J Liposome Res; 2020 Mar; 30(1):1-11. PubMed ID: 31010357
[TBL] [Abstract][Full Text] [Related]
58. Protection of epigallocatechin gallate against degradation during in vitro digestion using apple pomace as a carrier.
Wu L; Sanguansri L; Augustin MA
J Agric Food Chem; 2014 Dec; 62(50):12265-70. PubMed ID: 25419979
[TBL] [Abstract][Full Text] [Related]
59. Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles.
Wu S; Sun K; Wang X; Wang D; Wan X; Zhang J
J Agric Food Chem; 2013 Jul; 61(30):7268-75. PubMed ID: 23822637
[TBL] [Abstract][Full Text] [Related]
60. Broccoli byproducts for protection and co-delivery of EGCG and tuna oil.
Shi M; Ying DY; Ye JH; Sanguansri L; Augustin MA
Food Chem; 2020 Oct; 326():126963. PubMed ID: 32413754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
